Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Life Science Angels
AddedFeb 15, 2024
UpdatedJun 28, 2026
Life Science Angels

Life Science Angels

Operating

California-based VC group, Life Science Angels, funds early-stage healthcare and biotech firms.

Location
Sunnyvale, CA, US
Founded
2004
Firm
Compare
Portfolio
Employees
Website

Investments

Savage Medical
Savage Medical

Total Raised

$4.2M

Rounds

5

Series Unknown$3MNovember 2023
Avisi Technologies
Avisi Technologies

Total Raised

$10.2M

Rounds

9

Seed$6.3MOctober 2023
Seed$1.5MSeptember 2021
Astrocyte Pharmaceuticals
Astrocyte Pharmaceuticals

Total Raised

$31.9M

Rounds

11

Series B$6MAugust 2023
Series A$6MMay 2021
Allyx Therapeutics
Allyx Therapeutics

Total Raised

$10.1M

Rounds

4

Series Unknown$7.6MJune 2021
Series UnknownJanuary 2021
Strategikon Pharma
Strategikon Pharma

Total Raised

$25k

Rounds

4

Series AApril 2021
SeedDecember 2020
Visicell Medical
Visicell Medical

Total Raised

$255.5k

Rounds

2

Series UnknownMarch 2021
Saccharo
Saccharo

Total Raised

$7.4M

Rounds

3

Series UnknownJanuary 2021
Celldom
Celldom

Total Raised

$1.9M

Rounds

5

SeedJanuary 2021
Anubis Bio
Anubis Bio

Total Raised

$1M

Rounds

4

Seed$1MMarch 2020
Noctrix Health
Noctrix Health

Total Raised

$57M

Rounds

4

SeedMarch 2020
Inhalon Biopharma
Inhalon Biopharma

Total Raised

$11.9M

Rounds

4

SeedJanuary 2020
Sandstone Diagnostics
Sandstone Diagnostics

Total Raised

$14.5M

Rounds

23

Series UnknownJanuary 2020
Eumentis Therapeutics
Eumentis Therapeutics

Total Raised

$8.9M

Rounds

4

SeedJanuary 2020
S2 Genomics
S2 Genomics

Total Raised

$18.2M

Rounds

8

Series UnknownJanuary 2020
SeedDecember 2019
Stimwave Technologies
Stimwave Technologies
Acquired

Total Raised

$115.8M

Rounds

9

Series UnknownJanuary 2020
BioTrace Medical
BioTrace Medical
Acquired

Total Raised

$21.7M

Rounds

5

Series UnknownJanuary 2020
Embolx
Embolx

Total Raised

$2.5M

Rounds

6

SeedJune 2019
Chimera Bioengineering
Chimera Bioengineering

Total Raised

$30.7M

Rounds

6

Series Unknown$23.2MMay 2019
Chameleon Biosciences
Chameleon Biosciences

Total Raised

$14.2M

Rounds

5

Seed$3MMarch 2019
TeVido BioDevices
TeVido BioDevices

Total Raised

$3.7M

Rounds

9

Series Unknown$1.2MJanuary 2019